Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON - Allanore, Y; Vonk, M C; Azuma, A
Arthritis Rheumatol 2020; 72 (Suppl. 10)